Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

The SARS-CoV-2 virus emerged in December 2019 in Wuhan, China and then spread rapidly all over the world. Scientists are intensifying their research efforts in order to find antivirals specific to the virus and vaccines to treat or prevent COVID-19. Now, for a medicative cure for COVID-19, several d...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Amrit Krishna Mitra
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	AIMS Press 2020-12-01
Цуврал:	AIMS Molecular Science
Нөхцлүүд:	covid-19 sars-cov-2 chloroquine hydroxychloroquine lopinavir ritonavir remdesivir favipiravir vitamin c convalescent plasma
Онлайн хандалт:	http://www.aimspress.com/article/10.3934/molsci.2020012?viewType=HTML

Ижил төстэй зүйлс

Review of Clinical Trials in COVID-19: Trying to Solve the Clinicians’ Conundrum
-н: Amita Athavale, зэрэг
Хэвлэсэн: (2020-07-01)

COVID-19: An Update about the Discovery Clinical Trial
-н: Jean Jacques Vanden Eynde
Хэвлэсэн: (2020-05-01)

Therapeutic Strategies in the Management of COVID-19
-н: Rajashri R. Naik, зэрэг
Хэвлэсэн: (2021-02-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
-н: Subodh Kumar, зэрэг
Хэвлэсэн: (2021-01-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
-н: Jean Jacques Vanden Eynde
Хэвлэсэн: (2020-04-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
-н: Achal Mishra, зэрэг
Хэвлэсэн: (2021-06-01)

COVID-19 possible medical treatments
-н: Marzieh Mohammadi, зэрэг
Хэвлэсэн: (2021-01-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
-н: Abhi Bhadra, зэрэг
Хэвлэсэн: (2020-05-01)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
-н: Shahamah Jomah, зэрэг
Хэвлэсэн: (2020-09-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
-н: Sultan Ayoub Meo, зэрэг
Хэвлэсэн: (2020-10-01)

Comparison of effectiveness of various treatment strategies in COVID-19 patients: A Systematic Review
-н: Muhammad Shehryar Hussain, зэрэг
Хэвлэсэн: (2020-08-01)

Pharmacological management of COVID-19
-н: Veena Raghunathan, зэрэг
Хэвлэсэн: (2020-01-01)

An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
-н: A. S. Kolbin
Хэвлэсэн: (2020-05-01)

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19
-н: B. K. Romanov
Хэвлэсэн: (2020-09-01)

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
-н: Xinni Xu, зэрэг
Хэвлэсэн: (2020-05-01)

The Rationale for Potential Pharmacotherapy of COVID-19
-н: Maha Saber-Ayad, зэрэг
Хэвлэсэн: (2020-05-01)

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
-н: Qomara WF, зэрэг
Хэвлэсэн: (2021-11-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
-н: Milo Gatti, зэрэг
Хэвлэсэн: (2021-02-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
-н: David Grimaldi, зэрэг
Хэвлэсэн: (2020-10-01)

COVID-19 treatment in children: A systematic review and meta-analysis
-н: Prateek Kumar Panda, зэрэг
Хэвлэсэн: (2021-01-01)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
-н: Alina Kröker, зэрэг
Хэвлэсэн: (2021-11-01)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
-н: Stanković Biljana, зэрэг
Хэвлэсэн: (2020-01-01)

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
-н: Hayato Koba, зэрэг
Хэвлэсэн: (2020-12-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
-н: Abubakar AR, зэрэг
Хэвлэсэн: (2020-12-01)

Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
-н: hasan mohammed altemimy
Хэвлэсэн: (2020-06-01)

Efficacy of lopinavir/ritonavir plus interferon beta compared to hydroxychloroquine in the treatment of COVID-19: A retrospective observational study
-н: Motahareh Amirizadeh, зэрэг
Хэвлэсэн: (2023-01-01)

High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19
-н: Allan Ramos-Esquivel, зэрэг
Хэвлэсэн: (2022-06-01)

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents
-н: Shagun B Shah, зэрэг
Хэвлэсэн: (2021-01-01)

Progress in the Research and Development of Anti-COVID-19 Drugs
-н: Lianzhou Huang, зэрэг
Хэвлэсэн: (2020-07-01)

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
-н: A. Abayomi, зэрэг
Хэвлэсэн: (2021-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
-н: Muhammad Haroon Aftab, зэрэг
Хэвлэсэн: (2024-01-01)

Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
-н: Mehdi Hassaniazad, зэрэг
Хэвлэсэн: (2020-10-01)

Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
-н: Woon Yi Law, зэрэг
Хэвлэсэн: (2020-11-01)

The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
-н: Ayşe BATIREL, зэрэг
Хэвлэсэн: (2021-12-01)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
-н: Min Joo Choi, зэрэг
Хэвлэсэн: (2021-01-01)

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
-н: Justin T. Denholm, зэрэг
Хэвлэсэн: (2020-07-01)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
-н: Paolo Gaibani, зэрэг
Хэвлэсэн: (2021-03-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
-н: A. S. Zmitrukevich, зэрэг
Хэвлэсэн: (2024-01-01)

Determination of lopinavir/ritonavir concentrations in four different oral solutions for the application of antiretroviral therapy in very young, HIV-1-infected children
-н: Nils von Hentig, зэрэг
Хэвлэсэн: (2021-05-01)

Scoping insight on antiviral drugs against COVID-19
-н: Ahmed S. Ali, зэрэг
Хэвлэсэн: (2021-10-01)